3Ozaki H,Seo MS,Ozaki K,et al.Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization[J].Am J Pathol,2000,156(2):697-707.
4Clermont AC,Alello LP,Mori F,et al.Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo:a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy[J].Am J Ophthalmol,1997,124(4):433-446.
5Tolentino MJ,Miller JW,Gragoudas ES,et al.Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate[J].Ophthalmology,1996,103(11):1820-1828.
6Maisonpierre PC.Angiopoietin-2 a natural antagonist for Tie2that disrupts in vivo angiogenesis[J].Science,1997,277(5322):55-60.
7Mandriota SJ.Regulation of angiopoietin-2mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia[J].Circ Res,1998,83(8):852-859.
8Lyons T,Kimura M.Effect of modified low density lipproteins on cultured capillary cells,mitigation by pre-enrichment with α-tocopherol and mechanism of toxicity[J].Diabetes,1998,47(suppl 1):379-384.
9Brownlee M.Glycation and diabetic complication[J].Diabetes,1994,43(6):836-842.
10Chiasson JL,Joss RG,Gomis R,et al.A carbose for prevention of type 2 diabetesmellitus the stop-N ID DM random ized Lancet,2002,359 (9323):2072-2077.
二级参考文献6
1Reed JC.Bcl-2 and the regulation of programmed cell death[].The Journal of Cell Biology.1994
2Cory S.Regulation of lymphocyte survival by the bcl-2 gene family[].Annual Review of Immunology.1995
3Oltvai ZN,Milliman CL,Korsmeyer SJ.Bcl-2heterodimerizes in vivo with a conserved homolog,Bax,that accelerates programmed cell death[].Cell.1993
4Wyllie AH.Death gets a brake[].Nature.1994
5Boise LH,Gonzalez -Garcia M,Postema CE,et al.bcl -X, a bcl -2-related gene that functions as a dominant regulator of apoptotic cell death[].Cell.1993
6Negoescu A,Lorimier P,Labat-Moleur F,et al.TUNEL, improvement and evaluation of the method for in situ apoptotic cell identification[].Biochemica.1997
7Wautier JL, Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy[ J]. Diab Metabol, 2001,27 (5) : 535 -542
8Singh R, Barden A, Mori T, et al. Advanced glycation end products: a review[ J]. Diabetologia,2001,44: 129 - 146
9Tuo QH,Wang C,Yan FX,et al. MAPK pathway mediates the protective effects of onychin on oxidative stress-induced apoptosis in ECV304 endothelial cells [ J ]. Life Sci,2004,76 ( 5 ) : 487 - 497
10Fu XH, Wang L, Zhao H, et al. Synthesis of genistein derivatives and determination on their protective effects against vascular endothelial celldamages caused by hydrogen peroxide[ J]. Bioorgan Med Chem Lett, 2008,18:513 -517
